Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Connective tissue diseases

Nucleosomes and systemic sclerosis

Systemic sclerosis (SSc) is characterized by an abnormal immune response to innocuous antigens that might lead to autoantibody production. New observations suggest that nucleosomes can mediate both IgG production and B-cell proliferation, via Toll-like receptor signalling, and thereby affect the pathogenesis of SSc.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Yoshizaki, A. et al. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2015-207405 (2015).

  2. 2

    Amoura, Z. et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40, 2217–2225 (1997).

    CAS  Article  Google Scholar 

  3. 3

    Magna, M. & Pisetsky, D. S. The role of cell death in the pathogenesis of SLE: is pyroptosis the missing link? Scand. J. Immunol. 82, 218–224 (2015).

    CAS  Article  Google Scholar 

  4. 4

    Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).

    CAS  Article  Google Scholar 

  5. 5

    Ciechomska, M., van Laar, J. & O'Reilly, S. Current frontiers in systemic sclerosis pathogenesis. Exp. Dermatol. 24, 401–406 (2015).

    Article  Google Scholar 

  6. 6

    Fullard, N. & O'Reilly, S. Role of innate immune system in systemic sclerosis. Semin. Immunopathol. 37, 511–517 (2015).

    CAS  Article  Google Scholar 

  7. 7

    O'Reilly, S., Ciechomska, M., Cant, R. & van Laar, J. M. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 289, 9952–9960 (2014).

    CAS  Article  Google Scholar 

  8. 8

    Bosello, S.L. et al. Long term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin. Arthritis Rheum. 44, 428–436 (2015).

    Article  Google Scholar 

  9. 9

    Ciechomska, M. et al. Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann. Rheum. Dis. 72, 1382–1389 (2013).

    CAS  Article  Google Scholar 

  10. 10

    Balak, D.M.W. et al. http://www.iderapharma.com/wp-content/uploads/2015/11/imo-8400_psoriasis_aad_poster-final.pdf (2015).

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Steven O'Reilly or Jacob M. van Laar.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

O'Reilly, S., van Laar, J. Nucleosomes and systemic sclerosis. Nat Rev Rheumatol 12, 138–139 (2016). https://doi.org/10.1038/nrrheum.2016.9

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing